Neuropsychological and neuroimaging underpinnings of schizoaffective disorder: a systematic review

Acta Psychiatrica Scandinavica

Volumn 134, Issue 1, 2016, Pages 16-30

  Madre, M ^a   Canales Rodriguez E J ^a   Ortiz Gil, J ^a,b   Murru, A ^c   Torrent, C ^c   Bramon, E ^d   Perez, V ^e,f   Orth, M ^g   Brambilla, P ^h,i   Vieta, E ^c   Amann, B L ^a  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^b HOSPITAL GENERAL DE GRANOLLERS   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e HOSPITAL DEL MAR   (Spain)

^f INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^g UNIVERSITY OF ULM   (Germany)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ UNIVERSITY OF TEXAS   (United States)

Author keywords

bipolar disorder; neurocognition; neuroimaging; schizoaffective disorder; schizophrenia

Indexed keywords

BIPOLAR DISORDER; BRAIN ATROPHY; BRAIN SIZE; COGNITION; COGNITIVE DEFECT; DIFFUSION TENSOR IMAGING; ELECTROENCEPHALOGRAM; FUNCTIONAL NEUROIMAGING; GRAY MATTER; HUMAN; LONG TERM MEMORY; MAJOR DEPRESSION; MULTIMODAL IMAGING; NEUROBIOLOGY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYSTEMATIC REVIEW; VERBAL MEMORY; VOXEL BASED MORPHOMETRY; WHITE MATTER;

EID: 84973663825     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12564     Document Type: Review

References (107)

1. Kraepelin EE. Psychiatrie. 6th ed. Leipzig: Barth; 1899.
2. Kraepelin E. Die Erscheinungsformen des Irreseins. Zeitschrift für die gesamte Neurologie und Psychiatrie 1920;62:1–29.
3. Kasanin K. The acute schizoaffective psychoses. Am J Psychiatry 1933;90:97–126.
4. Peralta V, Cuesta MJ. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach. J Affect Disord 2008;108:71–86.
5. Kendler KS, Neale MC, Walsh D. Evaluating the spectrum concept of schizophrenia in the Roscommon Family Study. Am J Psychiatry 1995;152:749–754.
6. Crow TJ. The continuum of psychosis and its implication for the structure of the gene. Br J Psychiatry 1986;149:419–429.
7. Beck AT. Depression: Causes and Treatment. Philadelphia: University of Pennsylvania Press; 1967.
8. Welner A, Croughan J, Fishman R, Robins E. The group of schizoaffective and related psychoses: a follow-up study. Compr Psychiat 1977;18:413–422.
9. Lehman H. Schizophrenia: clinical features. In: Freedman A, Kaplan H, Saddock J, editors. Comprehensive Textbook of Psychiatry. Baltimore: Williams & Wilkins; 1975: pp 457–486.
10. Pope HG jr., Lipinski JF, Cohen BM, Axelrod DT. “Schizoaffective disorder”: an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder. Am J Psychiatry 1980;137:921–927.
11. Procci WR. Schizo-affective psychosis: fact or fiction? A survey of the literature. Arch Gen Psychiatry 1976;33:1167–1178.
12. Maier W. Do schizoaffective disorders exist at all? Acta Psychiat Scand 2006;113:369–371.
13. Lake CR, Hurwitz N. Schizoaffective disorders are psychotic mood disorders; there are no schizoaffective disorders. Psychiatry Res 2006;143:255–287.
14. APA. Diagnostic and statistical manual of mental disorders, 5th edn (DSM-V). Washington DC: American Psychiatric Association, 2013.
15. Cosgrove VE, Suppes T. Informing DSM-5: biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophrenia. BMC Med 2013;11:127.
16. Abrams DJ, Rojas DC, Arciniegas DB. Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature. Neuropsychiatr Dis Treat 2008;4:1089–1109.
17. Malhi GS, Green M, Fagiolini A, Peselow ED, Kumari V. Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disord 2008;10:215–230.
18. Haijma SV, Van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophrenia Bull 2013;39:1129–1138.
19. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry 2009;195:194–201.
20. Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008;65:1017–1032.
21. D'Albis MA, Houenou J. The kraepelinian dichotomy viewed by neuroimaging. Schizophrenia Bull 2015;41:330–335.
22. Trotta A, Murray RM, Maccabe JH. Do premorbid and post-onset cognitive functioning differ between schizophrenia and bipolar disorder? A systematic review and meta-analysis. Psychol Med 2015;45:381–394.
23. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
24. Miller LS, Swanson-Green T, Moses JA Jr., Faustman WO. Comparison of cognitive performance in RDC-diagnosed schizoaffective and schizophrenic patients with the Luria-Nebraska Neuropsychological Battery. J Psychiatr Res 1996;30:277–282.
25. Manschreck TC, Maher BA, Beaudette SM, Redmond DA. Context memory in schizoaffective and schizophrenic disorders. Schizophr Res 1997;26:153–161.
26. Evans JD, Heaton RK, Paulsen JS, McAdams LA, Heaton SC, Jeste DV. Schizoaffective disorder: a form of schizophrenia or affective disorder? J Clin Psychiatry 1999;60:874–882.
27. Gooding DC, Tallent KA. Spatial working memory performance in patients with schizoaffective psychosis versus schizophrenia: a tale of two disorders? Schizophr Res 2002;53:209–218.
28. Glahn DC, Bearden CE, Cakir S et al. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disord 2006;8:117–123.
29. Roofeh D, Cottone J, Burdick KE et al. Deficits in memory strategy use are related to verbal memory impairments in adolescents with schizophrenia-spectrum disorders. Schizophr Res 2006;85:201–212.
30. Goldstein G, Shemansky WJ, Allen DN. Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia. Arch Clin Neuropsychol 2005;20:153–159.
31. Stip E, Sepehry AA, Prouteau A et al. Cognitive discernible factors between schizophrenia and schizoaffective disorder. Brain Cogn 2005;59:292–295.
32. Fiszdon JM, Richardson R, Greig T, Bell MD. A comparison of basic and social cognition between schizophrenia and schizoaffective disorder. Schizophr Res 2007;91:117–121.
33. Torrent C, Martinez-Aran A, Amann B et al. Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects. Acta Psychiatr Scand 2007;116:453–460.
34. Szoke A, Meary A, Trandafir A et al. Executive deficits in psychotic and bipolar disorders - implications for our understanding of schizoaffective disorder. Eur Psychiat 2008;23:20–25.
35. Heinrichs RW, Ammari N, McDermid VAZS, Miles AA. Are schizophrenia and schizoaffective disorder neuropsychologically distinguishable? Schizophr Res 2008;99:149–154.
36. Reichenberg A, Harvey PD, Bowie CR et al. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophrenia Bull 2009;35:1022–1029.
37. Hooper SR, Giuliano AJ, Youngstrom EA et al. Neurocognition in early-onset schizophrenia and schizoaffective disorders. J Am Acad Child Adolesc Psychiatry 2010;49:52–60.
38. Studentkowski G, Scheele D, Calabrese P et al. Cognitive impairment in patients with a schizoaffective disorder: a comparison with bipolar patients in euthymia. Eur J Med Res 2010;15:70–78.
39. Simonsen C, Sundet K, Vaskinn A et al. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. Schizophr Bull 2011;37:73–83.
40. Amann B, Gomar JJ, Ortiz-Gil J et al. Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls. Psychol Med 2012;42:2127–2135.
41. Torniainen M, Suvisaari J, Partonen T et al. Cognitive impairments in schizophrenia and schizoaffective disorder: relationship with clinical characteristics. J Nerv Ment Dis 2012;200:316–322.
42. Derosse P, Burdick KE, Lencz T, Siris SG, Malhotra AK. Empirical support for DSM-IV schizoaffective disorder: clinical and cognitive validators from a large patient sample. PLoS ONE 2013;8:e63734.
43. Madre M, Radua J, Landin-Romero R et al. Trait or state? A longitudinal neuropsychological evaluation and fMRI study in schizoaffective disorder. Schizophr Res 2014;159:458–464.
44. Fleck DE, Delbello MP, Zimmerman ME, Getz GE, Shear PK, Strakowski SM. Selective attention in schizoaffective disorder: pilot data. Schizophr Res 2004;68:109–110.
45. Hill SK, Reilly JL, Keefe RS et al. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry 2013;170:1275–1284.
46. Buchanan RW, Davis M, Goff D et al. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 2005;31:5–19.
47. Bora E, Yucel M, Pantelis C. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. Br J Psychiatry 2009;195:475–482.
48. Palmer BW, Dawes SE, Heaton RK. What do we know about neuropsychological aspects of schizophrenia? Neuropsychol Rev 2009;19:365–384.
49. Murray RM, Sham P, van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 2004;71:405–416.
50. Rund BR. Is schizophrenia a neurodegenerative disorder? Nord J Psychiatry 2009;63:196–201.
51. Dickerson F, Schroeder J, Stallings C et al. A longitudinal study of cognitive functioning in schizophrenia: clinical and biological predictors. Schizophr Res 2014;156:248–253.
52. Martinez-Aran A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004;161:262–270.
53. Xu G, Lin K, Rao D et al. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study. J Affect Disord 2012;136:328–339.
54. Torrent C, Martinez-Aran A, Del Mar Bonnin C et al. Long-term outcome of cognitive impairment in bipolar disorder. J Clin Psychiatry 2012;73:e899–e905.
55. Mora E, Portella MJ, Forcada I, Vieta E, Mur M. Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study. Psychol Med 2013;43:1187–1196.
56. Amann BL, Canales-Rodríguez E, Madre M et al. Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder. Acta Psychiat Scand 2016;133:23–33.
57. Arnold SJ, Ivleva EI, Gopal TA et al. Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer). Schizophr Bull 2015;41:233–249.
58. Getz GE, Delbello MP, Fleck DE, Zimmerman ME, Schwiers ML, Strakowski SM. Neuroanatomic characterization of schizoaffective disorder using MRI: a pilot study. Schizophr Res 2002;55:55–59.
59. Gruber O, Gruber E, Falkai P. Articulatory rehearsal in verbal working memory: a possible neurocognitive endophenotype that differentiates between schizophrenia and schizoaffective disorder. Neurosci Lett 2006;405:24–28.
60. Ivleva EI, Bidesi AS, Keshavan MS et al. Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry 2013;170:1285–1296.
61. Ivleva EI, Bidesi AS, Thomas BP et al. Brain gray matter phenotypes across the psychosis dimension. Psychiatry Res 2012;204:13–24.
62. Jones PB, Harvey I, Lewis SW et al. Cerebral ventricle dimensions as risk factors for schizophrenia and affective psychosis: an epidemiological approach to analysis. Psychol Med 1994;24:995–1011.
63. Kalayci D, Ozdel O, Sozeri-Varma G, Kiroglu Y, Tumkaya S. A proton magnetic resonance spectroscopy study in schizoaffective disorder: comparison of bipolar disorder and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2012;37:176–181.
64. Landin-Romero R, Canales-Rodríguez EJ, Kumfor F et al. White matter and cortical thickness abnormalities in schizoaffective disorder: A multimodal MRI study. Aust NZ J Psychiat 2016; pii: 0004867416631827. [Epub ahead of print].
65. Lewine RR, Hudgins P, Brown F, Caudle J, Risch SC. Differences in qualitative brain morphology findings in schizophrenia, major depression, bipolar disorder, and normal volunteers. Schizophr Res 1995;15:253–259.
66. Madre M, Pomarol-Clotet E, McKenna P et al. Brain functional abnormality in schizo-affective disorder: an fMRI study. Psychol Med 2013;43:143–153.
67. Mathew I, Gardin TM, Tandon N et al. Medial Temporal Lobe Structures and Hippocampal Subfields in Psychotic Disorders: Findings From the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study. JAMA Psychiatry 2014;71():769–777.
68. Ongur D, Lundy M, Greenhouse I et al. Default mode network abnormalities in bipolar disorder and schizophrenia. Psychiatry Res 2010;183:59–68.
69. Padmanabhan JL, Tandon N, Haller CS et al. Correlations between brain structure and symptom dimensions of psychosis in schizophrenia, schizoaffective, and psychotic bipolar I disorders. Schizophr Bull 2015;41:154–162.
70. Radonic E, Rados M, Kalember P, Bajs-Janovic M, Folnegovic-Smalc V, Henigsberg N. Comparison of hippocampal volumes in schizophrenia, schizoaffective and bipolar disorder. Coll Antropol 2011;35(Suppl 1):249–252.
71. Rieder RO, Mann LS, Weinberger DR, van Kammen DP, Post RM. Computed tomographic scans in patients with schizophrenia, schizoaffective, and bipolar affective disorder. Arch Gen Psychiat 1983;40:735–739.
72. Smith MJ, Wang L, Cronenwett W, Mamah D, Barch DM, Csernansky JG. Thalamic morphology in schizophrenia and schizoaffective disorder. J Psychiatr Res 2011;45:378–385.
73. Du Y, Pearlson GD, Liu J et al. A group ICA based framework for evaluating resting fMRI markers when disease categories are unclear: Application to schizophrenia, bipolar, and schizoaffective disorders. NeuroImage 2015;122:272–280.
74. Pomarol-Clotet E, Canales-Rodríguez EJ, Salvador R et al. Medial prefrontal cortex pathology in schizophrenia as revealed by convergent findings from multimodal imaging. Mol Psychiatr 2010;15:823–830.
75. Canales-Rodríguez EJ, Pomarol-Clotet E, Radua J et al. Structural abnormalities in bipolar euthymia: a multicontrast molecular diffusion imaging study. Biol Psychiatry 2014;76:239–248.
76. Pomarol-Clotet E, Alonso-Lana S, Moro N et al. Brain functional changes across the different phases of bipolar disorder. Br J Psychiatry 2014;206:136–144.
77. Pomarol-Clotet E, Salvador R, Sarro S et al. Failure to deactivate in the prefrontal cortex in schizophrenia: dysfunction of the default mode network? Psychol Med 2008;38:1185–1193.
78. Whitfield-Gabrieli S, Thermenos HW, Milanovic S et al. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A 2009;106:1279–1284.
79. Milanovic SM, Thermenos HW, Goldstein JM et al. Medial prefrontal cortical activation during working memory differentiates schizophrenia and bipolar psychotic patients: A pilot FMRI study. Schizophr Res 2011;129:208–210.
80. Salgado-Pineda P, Fakra E, Delaveau P, McKenna PJ, Pomarol-Clotet E, Blin O. Correlated structural and functional brain abnormalities in the default mode network in schizophrenia patients. Schizophr Res 2011;125:101–109.
81. Schneider FC, Royer A, Grosselin A et al. Modulation of the default mode network is task-dependant in chronic schizophrenia patients. Schizophr Res 2011;125:110–117.
82. Murru A, Pacchiarotti I, Nivoli AM, Colom F, Vieta E. Is schizoaffective disorder still a neglected condition in the scientific literature? Psychother Psychosom 2012;81:389–390.
83. Freedman R, Lewis DA, Michels R et al. The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry 2013;170:1–5.
84. Salvatore P, Baldessarini RJ, Tohen M et al. McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry 2011;72:183–193.
85. Robinson LJ, Thompson JM, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affec Disorders 2006;93:105–115.
86. Mann-Wrobel MC, Carreno JT, Dickinson D. Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. Bipolar Disord 2011;13:334–342.
87. Ellison-Wright I, Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res 2010;117:1–12.
88. Bora E, Fornito A, Yucel M, Pantelis C. The effects of gender on grey matter abnormalities in major psychoses: a comparative voxelwise meta-analysis of schizophrenia and bipolar disorder. Psychol Med 2012;42:295–307.
89. de Peri L, Crescini A, Deste G, Fusar-Poli P, Sacchetti E, Vita A. Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr Pharm Des 2012;18:486–494.
90. Broyd SJ, Demanuele C, Debener S, Helps SK, James CJ, Sonuga-Barke EJ. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav Rev 2009;33:279–296.
91. Gusnard DA, Raichle ME. Searching for a baseline: functional imaging and the resting human brain. Nat Rev Neurosci 2001;2:685–694.
92. Raichle ME, Macleod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci U S A 2001;98:676–682.
93. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 2008;1124:1–38.
94. Gusnard DA. Being a self: considerations from functional imaging. Conscious Cogn 2005;14:679–697.
95. Clayton PJ, Rodin L, Winokur G. Family history studies. 3. Schizoaffective disorder, clinical and genetic factors including a one to two year follow-up. Compr Psychiatry 1968;9:31–49.
96. Dell'osso L, Akiskal HS, Freer P, Barberi M, Placidi GF, Cassano GB. Psychotic and nonpsychotic bipolar mixed states: comparisons with manic and schizoaffective disorders. Eur Arch Psychiatry Clin Neurosci 1993;243:75–81.
97. Laursen TM, Labouriau R, Licht RW, Bertelsen A, Munk-Olsen T, Mortensen PB. Family history of psychiatric illness as a risk factor for schizoaffective disorder: a Danish register-based cohort study. Arch Gen Psychiatry 2005;62:841–848.
98. Cheniaux E, Landeira-Fernandez J, Lessa Telles L et al. Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders J Affect Disord 2008;106:209–217.
99. Marneros A, Deister A, Rohde A. Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course. Acta Psychiatr Scand 1990;82:352–358.
100. Kendler KS, McGuire M, Gruenberg AM, Walsh D. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study. Am J Psychiatry 1995;152:755–764.
101. Benabarre A, Vieta E, Colom F, Martinez-Aran A, Reinares M, Gasto C. Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences. Eur Psychiat 2001;16:167–172.
102. van Os J, Kapur S. Schizophrenia. Lancet 2009;374:635–645.
103. LEHMAN H, editor. Schizophrenia: clinical features. Baltimore: Williams & Wilkins; 1975.
104. Pagel T, Baldessarini RJ, Franklin J, Baethge C. Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder. Bipolar Disord 2013;15:229–239.
105. Olfson M, Marcus SC, Wan GJ. Treatment patterns for schizoaffective disorder and schizophrenia among Medicaid patients. Psychiatr Serv 2009;60:210–216.
106. Schumann G, Binder EB, Holte A et al. Stratified medicine for mental disorders. Eur Neuropsychopharmacol 2014;24:5–50.
107. Vieta E. Individualizing treatment for patients with schizoaffective disorder. J Clin Psychiatry 2010;71:e26.